CN101862428B - Chinese medicament for treating benign prostatic hyperplasia - Google Patents
Chinese medicament for treating benign prostatic hyperplasia Download PDFInfo
- Publication number
- CN101862428B CN101862428B CN2010102251966A CN201010225196A CN101862428B CN 101862428 B CN101862428 B CN 101862428B CN 2010102251966 A CN2010102251966 A CN 2010102251966A CN 201010225196 A CN201010225196 A CN 201010225196A CN 101862428 B CN101862428 B CN 101862428B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- prostatic hyperplasia
- chinese medicine
- urinary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicament for treating benign prostatic hyperplasia, which comprises the following components in part by weight: 1 to 10 parts of panax ginseng, 1 to 10 parts of astragalus, 1 to 10 parts of notoginseng root, 1 to 10 parts of cinnamomvine, 1 to 10 parts of oriental waterplantain rhizome, 1 to 10 parts of south dodder seed, 1 to 10 parts of sharpleaf galangal fruit, 1 to 10 parts of peach seed, 1 to 10 parts of Chinese thorowax root, 1 to 10 parts of largetrifoliolious bugbane rhizome, 1 to 10 parts of liquoric root and 1 to 10 parts of ricepaperplant pith. The Chinese medicament has the effects on middle-jiao regulation, kidney reinforcement, discharge and retention of body fluid and abdominal mass elimination, has the main effects of tonifying the kidney and consolidating the constitution, controlling salivation, elevating yang qi, eliminating abdominal mass and inducing diuresis, ascending lucid yang, descending turbid yin, opening and closing in order and prolonging the longevity, and is suitable for curers who need operation or patients who cannot perform operation due to health or other reasons in middle and old-aged men who suffer from frequent micturition, urgent urination, small urinary stream, acraturesis, urinary dribbling, urinary hesitancy, urinary incontinence and urine retention which are caused by benign prostatic hyperplasia and hypertrophy.
Description
Technical field
The present invention relates to a kind of Chinese medicine of treating prostatic hyperplasia.
Background technology
Prostatic hyperplasia is claimed that prostate hyperplasia be the common disease of middle-aging male not only but also is claimed that benign prostatauxe hypertrophy body of gland is positioned at neck of bladder, makes urinary tract obstruction, causes that the early stage wall of urinary bladder flesh of frequent micturition and dysuria layer thickens; Can overcome the cervical region resistance and drain urine; Along with body of gland increases, surpassed the compensatory capacity of bladder gradually, the just residual bladder of urine; Symptom increases the weight of thereupon, even urine retention takes place or go up urinary tract hydrops.Present normally used Therapeutic Method comprises physics vcd therapy for treating, operative treatment and Drug therapy, and the wound that operative treatment can be bigger to patient's premature labor can not be as the conventional method of treatment prostatic hyperplasia; Physics vcd therapy is to utilize functions such as high frequency far-infrared electromagnetic can force the ducts of prostate gland open drainage; Source of disease microorganism and metabolite in the body of prostate are excreted along urethra, improve and promotion body of prostate blood circulation, alleviate the congested pressure of body of prostate to reach; But this method treatment cycle is long; And this method mainly is in order to treat prostatitis, only has the effect of alleviation for prostatic hyperplasia, can not fundamentally eliminate outgrowth prostata tissue; Existing Drug therapy is divided into Chinese medicine and western medicine, but all has the shortcoming that treatment cycle is long, be prone to recurrence, and the effect of treatment is undesirable, and also there is the bigger problem of side effect in western medicine.
Summary of the invention
The purpose of this invention is to provide that a kind of curative effect is fast, the treatment short treating period, the Chinese medicine preparation of the treatment prostatic hyperplasia that difficult recurrence has no side effect.
In order to realize above purpose; The technical scheme that the present invention adopted is: a kind of Chinese medicine of treating prostatic hyperplasia comprises the raw material of following weight portion: Radix Ginseng 1-10 part, Radix Astragali 1-10 part, Radix Notoginseng 1-10 part, Rhizoma Dioscoreae 1-10 part, Rhizoma Alismatis 1-10 part, Semen Cuscutae 1-10 part, Fructus Alpiniae Oxyphyllae 1-10 part, Semen Persicae 1-10 part, Radix Bupleuri 1-10 part, Rhizoma Cimicifugae 1-10 part, Radix Glycyrrhizae 1-10 part, Medulla Tetrapanacis 1-10 part.
Chinese medicine of the present invention is applicable to that middle-aging male prostatic hyperplasia, loose frequent micturition because of it, urgent micturition, urine line are thin, acraturesis, dribbling, urine wait, urinary incontinence, urine retention, the surgical treatment person, or because of the health other reasons can not operator.
Chinese medicine of the present invention has in the accent, reinforce the kidney, open the function of entire 、ization wei, and main effect is a reinforcing kidney and strengthening resistance, take the photograph receive, ascending ，ization wei diuretic, make clearly and rise, turbid decline, open entire in order, life prolonging.The function of concrete every flavor Chinese medicinal components with the effect as follows: Radix Ginseng: QI invigorating, admittedly take off, promote the production of body fluid, calm the nerves; The Radix Astragali: benefiting qi and raising yang, strengthening superficial resistance to stop perspiration, inducing diuresis to remove edema, promoting pus discharge and tissue regeneration strengthening; Radix Notoginseng: hemostasis dissipating blood stasis, subduing swelling and relieving pain; Rhizoma Dioscoreae: spleen reinforcing, support lung, to reinforce the kidney, benefit is smart; Rhizoma Alismatis: promoting diuresis to eliminate damp pathogen, it is treating stranguria to expel the heat-evil; Semen Cuscutae: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity; Fructus Alpiniae Oxyphyllae: the warming spleen and stopping diarrha saliva of taking the photograph, warming the kidney reducing urination controlling nocturnal emission with astringent drugs; Semen Persicae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Radix Bupleuri: induce sweat and bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy; Rhizoma Cimicifugae: deliver rash, heat-clearing and toxic substances removing, ascending up spleen-Qi and Yang; Radix Glycyrrhizae: with middle emergency, lung moistening, detoxifcation, coordinating the actions of various ingredients in a prescription; Medulla Tetrapanacis: clearing away heat and promoting diuresis.
Chinese medicine of the present invention can be equipped with accessory drugs different serious symptoms is carried out the specific aim treatment: for the urine retention symptom, can in main formula, add the raw material of following weight portion: Semen Plantaginis 1-30 part, Caulis Akebiae 1-6 part; Semen Plantaginis wherein: heat clearing away, diuresis, item; Caulis Akebiae: clearing away heat and promoting diuresis, blood circulation and channel invigorating.For the frequent micturition symptom, can in main formula, add the raw material of following weight portion: Radix Aconiti Lateralis Preparata 1-15 part, Cortex Cinnamomi 1-10 part, Semen Euryales 1-20 part, Ootheca Mantidis 1-10 part, Fructus Rubi 1-10 part; Radix Aconiti Lateralis Preparata wherein: recuperating depleted YANG and rescuing the patient from collapse, dispelling cold and removing dampness; Semen Euryales: reinforcing the kindey to control nocturnal emission, spleen reinforcing antidiarrheal; Ootheca Mantidis: controlling nocturnal emission with astringent drugs reducing urination, reinforcing the kidney and supporting YANG; Fructus Rubi: invigorating the liver and kidney benefit, controlling nocturnal emission with astringent drugs reducing urination.For the bitter symptom of xerostomia, can in main formula, add the raw material of weight portion: Radix Glycyrrhizae uralensis 1-30 part, Medulla Junci 1-6 part, Herba Houttuyniae 1-30 part, Radix Sophorae Flavescentis 1-30 part, Talcum 1-30 part, Semen Armeniacae Amarum 1-10 part; Radix Glycyrrhizae uralensis wherein: let out the fire detoxifcation; Medulla Junci: relieving stranguria by diuresis, clearing heart fire; Herba Houttuyniae: heat-clearing and toxic substances removing, removing pus and relieving carbuncle, inducing diuresis for treating stranguria syndrome; Radix Sophorae Flavescentis: heat clearing and damp drying, dispel the wind; Talcum: inducing diuresis for treating stranguria syndrome, clearing away summer-heat; Semen Armeniacae Amarum: lowering the adverse-rising QI to resolve phlegm, relieving cough and asthma, loosening bowel to relieve constipation.
Main formula of the present invention adopts conventional method to process granule, and concrete grammar is referring to " pharmacy of Chinese materia medica " higher medical universities and colleges teaching material, front page Shanghai science tech publishing house in 1986.Whenever pharmaceutically active ingredient 15g in including, 3-6 bag for each person every day when taking, the accessory drugs that adopts to the bitter symptom of urine retention, frequent micturition and xerostomia takes with decocting soup.
Chinese medicine of the present invention is for the prostatoplasia diseases instant effect, and symptom can significantly alleviate in 5-10 day, takes with continued and carries out after treatment; Have no side effect, can not recur, effect is remarkable; 100 routine prostatic hyperplasia patients to taking Chinese medicine of the present invention carry out statistical analysis; Take that to cure in the person in of the present invention be 85 people, effect is alleviator 14 people greatly, nonresponder 1 people.The effective percentage of final Chinese medicine of the present invention is 99%, good effect.
The specific embodiment
Embodiment 1
The Chinese medicine of the treatment prostatic hyperplasia of present embodiment comprises the component of following weight portion: 1 part of Radix Ginseng, 5 parts of the Radixs Astragali, 5 parts of Radix Notoginseng, 5 parts of Rhizoma Dioscoreaes, 1 part of Rhizoma Alismatis, 10 parts of Semen Cuscutae, 10 parts of Fructus Alpiniae Oxyphyllae, 5 parts in Semen Persicae, 5 parts of Radix Bupleuri, 1 part of Rhizoma Cimicifugae, 10 parts in Radix Glycyrrhizae, 10 parts of Medulla Tetrapanaciss.More than be the main formula Chinese medicine of present embodiment, in main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to urine retention symptom present embodiment: 1 part of Semen Plantaginis, 4 parts of Caulis Akebiaes.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to frequent micturition symptom present embodiment: 1 part of Radix Aconiti Lateralis Preparata, 4 parts of Cortex Cinnamomis, 20 parts of Semen Euryaless, 7 parts of Ootheca Mantidiss, 3 parts of Fructus Rubies.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to the bitter symptom present embodiment of xerostomia: 1 part of Radix Glycyrrhizae uralensis, 2 parts of Medulla Juncies, 20 parts of Herba Houttuyniae, 30 parts of Radix Sophorae Flavescentiss, 10 parts in Talcum, 3 parts in Semen Armeniacae Amarum.
Embodiment 2
The Chinese medicine of the treatment prostatic hyperplasia of present embodiment comprises the component of following weight portion: 5 parts of Radix Ginsengs, 10 parts of the Radixs Astragali, 10 parts of Radix Notoginseng, 10 parts of Rhizoma Dioscoreaes, 5 parts of Rhizoma Alismatis, 1 part of Semen Cuscutae, 1 part of Fructus Alpiniae Oxyphyllae, 10 parts in Semen Persicae, 10 parts of Radix Bupleuri, 5 parts of Rhizoma Cimicifugaes, 1 part in Radix Glycyrrhizae, 1 part of Medulla Tetrapanacis.More than be the main formula Chinese medicine of present embodiment, in main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to urine retention symptom present embodiment: 10 parts of Semen Plantaginiss, 6 parts of Caulis Akebiaes.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to frequent micturition symptom present embodiment: 5 parts of Radix Aconiti Lateralis Preparata, 10 parts of Cortex Cinnamomis, 10 parts of Semen Euryaless, 3 parts of Ootheca Mantidiss, 1 part of Fructus Rubi.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to the bitter symptom present embodiment of xerostomia: 10 parts of Radix Glycyrrhizae uralensiss, 1 part of Medulla Junci, 30 parts of Herba Houttuyniae, 10 parts of Radix Sophorae Flavescentiss, 20 parts in Talcum, 1 part in Semen Armeniacae Amarum.
Embodiment 3
The Chinese medicine of the treatment prostatic hyperplasia of present embodiment comprises the component of following weight portion: 10 parts of Radix Ginsengs, 1 part of the Radix Astragali, 1 part of Radix Notoginseng, 1 part of Rhizoma Dioscoreae, 10 parts of Rhizoma Alismatis, 5 parts of Semen Cuscutae, 5 parts of Fructus Alpiniae Oxyphyllae, 1 part in Semen Persicae, 1 part of Radix Bupleuri, 10 parts of Rhizoma Cimicifugaes, 5 parts in Radix Glycyrrhizae, 5 parts of Medulla Tetrapanaciss.More than be the main formula Chinese medicine of present embodiment, in main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to urine retention symptom present embodiment: 20 parts of Semen Plantaginiss, 2 parts of Caulis Akebiaes.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to frequent micturition symptom present embodiment: 10 parts of Radix Aconiti Lateralis Preparata, 8 parts of Cortex Cinnamomis, 1 part of Semen Euryales, 1 part of Ootheca Mantidis, 10 parts of Fructus Rubies.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to the bitter symptom present embodiment of xerostomia: 20 parts of Radix Glycyrrhizae uralensiss, 6 parts of Medulla Juncies, 1 part of Herba Houttuyniae, 20 parts of Radix Sophorae Flavescentiss, 30 parts in Talcum, 7 parts in Semen Armeniacae Amarum.
Embodiment 4
The Chinese medicine of the treatment prostatic hyperplasia of present embodiment comprises the component of following weight portion: 10 parts of Radix Ginsengs, 5 parts of the Radixs Astragali, 5 parts of Radix Notoginseng, 5 parts of Rhizoma Dioscoreaes, 5 parts of Rhizoma Alismatis, 5 parts of Semen Cuscutae, 5 parts of Fructus Alpiniae Oxyphyllae, 1 part in Semen Persicae, 1 part of Radix Bupleuri, 10 parts of Rhizoma Cimicifugaes, 5 parts in Radix Glycyrrhizae, 5 parts of Medulla Tetrapanaciss.More than be the main formula Chinese medicine of present embodiment, in main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to urine retention symptom present embodiment: 30 parts of Semen Plantaginiss, 1 part of Caulis Akebiae.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to frequent micturition symptom present embodiment: 15 parts of Radix Aconiti Lateralis Preparata, 1 part of Cortex Cinnamomi, 15 parts of Semen Euryaless, 10 parts of Ootheca Mantidiss, 7 parts of Fructus Rubies.In main formula Chinese medicine, also add the accessory drugs component that following weight portion is arranged to the bitter symptom present embodiment of xerostomia: 30 parts of Radix Glycyrrhizae uralensiss, 4 parts of Medulla Juncies, 10 parts of Herba Houttuyniae,, 1 part of Radix Sophorae Flavescentis, 1 part in Talcum, 10 parts in Semen Armeniacae Amarum.
Concrete case is following:
1, Lee so-and-so, 72 years old, excessive drinking caused prostate hyperplasia 3 years, occurred frequent micturition, urgent micturition, the sound of rain pattering endlessly, gradually to urine retention, the drop difficulty goes out, and causes health extremely weak.Routine blood test: WBC 2.6 * 109/L, Hb 40g/L, RBC 0.47 * 1012/L, electrocardiogram: ischemia changes, B ultrasonic: prostate 6.1 * 4.3 * 3.7cm, peplos fills whole, and the inner four tones of standard Chinese pronunciation are even, and complexion is wilted, and it is weak to pant, light red tongue, greasy and thin fur, deep and weak pulse is like unit.Give the main formula Chinese medicine of embodiment 1, take out urinary catheter after five days, urinate freely, and the shake of hand tremor for many years also disappears B ultrasonic check prostate 4.0 * 3.0 * 2.0cm, clinical cure, 5 years so far, efficacy consolidation thereupon.
2, Liu so-and-so, 42 years old, dysuria, urine is waited for 2 years, urine appears in patient's unknown cause before 2 years to be waited for, dysuria, urine retention is mixed lower abdomen, perineum and is weighed down and expand uncomfortablely, detects prostate 5.1 * 4.3 * 3.6cm through B ultrasonic, the inner four tones of standard Chinese pronunciation are even, peplos is complete.Give the main formula Chinese medicine ten days among the embodiment 2, urine waits for and disappearing that urinating is prone to, and lower abdomen, perineum weigh down to expand and alleviate, and sexual impotence is also significantly improved for many years, continues to strengthen treatment half a year.Followed up a case by regular visits to no longer recurrence, efficacy consolidation 4 years.
3, sternly certain, 76 years old, frequent micturition was many, the sound of rain pattering not to the utmost, enuresis nocturna, 6 years, the time heavy when light, blood pressure 175/130Hmg, B ultrasonic shows, prostate 5.3 * 4.7 * 3.9cm, the inner four tones of standard Chinese pronunciation are even, cardiopulmonary: (one), slight brain atrophy.Give embodiment 3 main formula and to the accessory drugs of frequent micturition ten days, symptom is more preceding greatly to be alleviated, and continues administration and consolidates in three months, follows up a case by regular visits to not recurrence in 3 years, evident in efficacy.
4, Pueraria lobota so-and-so, 72 years old, suffer from tracheitis, diseases such as emphysema because of left renal calculus hydrops, cause the slight atrophy of kidney, follow prostate hyperplasia simultaneously, urine retention, it is weak to pant, lethargy, poor appetite.Give main formula among the embodiment 4 and to the accessory drugs of urine retention ten days, urine retention was opened, asthma disappears, and diet two is just normal, consciously feels more strong, continues to take medicine five months, does not have recurrence again, efficacy consolidation.
Claims (1)
1. Chinese medicine of treating prostatic hyperplasia, it is characterized in that: the component by following weight portion is formed: Radix Ginseng 1-10 part, Radix Astragali 1-10 part, Radix Notoginseng 1-10 part, Rhizoma Dioscoreae 1-10 part, Rhizoma Alismatis 1-10 part, Semen Cuscutae 1-10 part, Fructus Alpiniae Oxyphyllae 1-10 part, Semen Persicae 1-10 part, Radix Bupleuri 1-10 part, Rhizoma Cimicifugae 1-10 part, Radix Glycyrrhizae 1-10 part, Medulla Tetrapanacis 1-10 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102251966A CN101862428B (en) | 2010-07-13 | 2010-07-13 | Chinese medicament for treating benign prostatic hyperplasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102251966A CN101862428B (en) | 2010-07-13 | 2010-07-13 | Chinese medicament for treating benign prostatic hyperplasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101862428A CN101862428A (en) | 2010-10-20 |
| CN101862428B true CN101862428B (en) | 2012-01-25 |
Family
ID=42954486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102251966A Expired - Fee Related CN101862428B (en) | 2010-07-13 | 2010-07-13 | Chinese medicament for treating benign prostatic hyperplasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101862428B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526428A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
| CN102526584B (en) * | 2012-03-27 | 2013-09-11 | 郑州密丽药业有限公司 | Chinese medicine for treating prostate disease and preparation method thereof |
| CN103768478B (en) * | 2012-10-23 | 2016-05-11 | 葛继云 | One is treated prostatitic Chinese medicine composition and its production and use |
| CN103919823A (en) * | 2014-04-13 | 2014-07-16 | 胡素芳 | Antispasmodic preparation method |
| CN104825729A (en) * | 2015-04-28 | 2015-08-12 | 广西大学 | Traditional Chinese medicine preparation for treating prostatitis |
| CN106606575A (en) * | 2016-12-27 | 2017-05-03 | 山东中医药大学 | Traditional Chinese medicine composition for treating night frequent micturition caused by geriatric male prostatitis diseases |
| CN106474410A (en) * | 2016-12-28 | 2017-03-08 | 陕西红顶名医堂药业有限公司 | For treating Chinese medicine composition of chronic prostatitiss and preparation method thereof |
| CN107715035A (en) * | 2017-10-25 | 2018-02-23 | 成都泠汐尚品科技有限公司 | A kind of Chinese medicine composition of effectively treatment hyperplasia of prostate |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1451418A (en) * | 2002-04-18 | 2003-10-29 | 鲁南制药股份有限公司 | Chinese medicine and prescription for treatment of hypertrophy of prostate |
-
2010
- 2010-07-13 CN CN2010102251966A patent/CN101862428B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1451418A (en) * | 2002-04-18 | 2003-10-29 | 鲁南制药股份有限公司 | Chinese medicine and prescription for treatment of hypertrophy of prostate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101862428A (en) | 2010-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101862428B (en) | Chinese medicament for treating benign prostatic hyperplasia | |
| CN101732660B (en) | Chinese medicinal preparation for treating prostate disease and preparation method thereof | |
| CN101564521B (en) | External plaster for treating hyperplasia of mammary glands | |
| CN1315526C (en) | Chinese herbal medicine for treating lumbar intervertebral disk protrusion and hyperosteogeny | |
| CN100531768C (en) | Medicament for treating chronic prostatitis and prostatic hyperplasia | |
| CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
| CN101972402A (en) | Chinese medicament for treating prostatitis | |
| CN103110766A (en) | Traditional Chinese medical composition for treating postpartum urinary retention | |
| CN102579897A (en) | Medicine for treating postoperative uroschesis of anorectal diseases and preparation method thereof | |
| CN101130000A (en) | Traditional Chinese medicine for treating postoperative constipation | |
| CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
| CN101732602B (en) | Medicament for treating calculi and preparation method thereof | |
| CN103599472B (en) | A kind of Chinese medicine composition being used for the treatment of prostatic hyperplasia | |
| CN103041262A (en) | Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof | |
| CN101732667B (en) | Traditional Chinese medicine for eliminating blood stasis and smoothing collaterals | |
| CN102240370B (en) | Chinese medicinal composition for treating benign prostatic hyperplasia and preparation method thereof | |
| CN103655845A (en) | Traditional Chinese medicine composition for treating uterine prolapse | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN105031505A (en) | Medicine for treating benign prostatic hyperplasia hypertrophy and preparation method thereof | |
| CN104162026A (en) | Traditional Chinese medicine composition treating hypertension and preparation method thereof | |
| CN102240384B (en) | Medicament for treating phlegm-stasis accumulating type epilepsy and preparation method thereof | |
| CN102366591B (en) | Chinese herbal medicinal wine for treating rheumatoid and rheumatoid arthritis and its preparation method | |
| CN101204566B (en) | Peroral Chinese traditional medicine composite for hyperosteogeny in knee joint | |
| CN105943744A (en) | Traditional Chinese medicine composition for treating retention of urine | |
| CN105687865A (en) | Traditional Chinese medicine composition for treating stranguria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 467001, No. 4, building No. 21, Zhongxing North Road, Zhongxing North Road, Xinhua District, Henan, Pingdingshan 32 Applicant after: Zhang Heting Address before: Suiping County Post Office in Zhumadian City, Henan province 463100 Zhang Yuzhuan Applicant before: Zhang Heting |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120125 Termination date: 20130713 |